First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP‐ribose) Polymerase‐1 Inhibitor, JPI-289, in Healthy Volunteers

• Main Authors: Han S (Author), Kim YH (Author), Choi HY (Author), Soh DJ (Author), Kim J (Author), Nam J (Author), Kim JW (Author), Bae KS (Author), Lim HS (Author)
• Format: Book
• Published: Dove Medical Press, 2020-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Sungpil Han,1 Yo Han Kim,1 Hee Youn Choi,1 Dong-Jun Soh,2 Jeongmin Kim,2 Joonwoo Nam,2 Jong-Woo Kim,2 Kyun-Seop Bae,1 Hyeong-Seok Lim1 1Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; 2Clinical Development...